Matthew Mark Weiss - Publications

Affiliations: 
2001 Yale University, New Haven, CT 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cheng Y, Brown J, Judd TC, Lopez P, Qian W, Powers TS, Chen JJ, Bartberger MD, Chen K, Dunn RT, Epstein O, Fremeau RT, Harried S, Hickman D, Hitchcock SA, ... ... Weiss MM, et al. An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities. Acs Medicinal Chemistry Letters. 6: 210-5. PMID 25699151 DOI: 10.1021/ml500458t  0.491
2015 Chen JJ, Liu Q, Yuan C, Gore V, Lopez P, Ma V, Amegadzie A, Qian W, Judd TC, Minatti AE, Brown J, Cheng Y, Xue M, Zhong W, Dineen TA, ... ... Weiss MM, et al. Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious β-secretase inhibitors for the potential treatment of Alzheimer's disease. Bioorganic & Medicinal Chemistry Letters. 25: 767-74. PMID 25613679 DOI: 10.1016/J.Bmcl.2014.12.092  0.467
2014 Epstein O, Bryan MC, Cheng AC, Derakhchan K, Dineen TA, Hickman D, Hua Z, Human JB, Kreiman C, Marx IE, Weiss MM, Wahl RC, Wen PH, Whittington DA, Wood S, et al. Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors. Journal of Medicinal Chemistry. 57: 9796-810. PMID 25389560 DOI: 10.1021/Jm501266W  0.499
2014 Dineen TA, Chen K, Cheng AC, Derakhchan K, Epstein O, Esmay J, Hickman D, Kreiman CE, Marx IE, Wahl RC, Wen PH, Weiss MM, Whittington DA, Wood S, Fremeau RT, et al. Inhibitors of β-site amyloid precursor protein cleaving enzyme (BACE1): identification of (S)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5'H-spiro[chromeno[2,3-b]pyridine-5,4'-oxazol]-2'-amine (AMG-8718). Journal of Medicinal Chemistry. 57: 9811-31. PMID 25363711 DOI: 10.1021/Jm5012676  0.508
2009 Navarro Villalobos M, Wood JL, Jeong S, Benson CL, Zeman SM, McCarty C, Weiss MM, Salcedo A, Jenkins J. Total syntheses of (+)- and (-)-syringolides 3 and of (+)- and (-)-syributins 1, 2 and 3 Tetrahedron. 65: 8091-8098. DOI: 10.1016/J.Tet.2009.07.055  0.594
2008 Harmange JC, Weiss MM, Germain J, Polverino AJ, Borg G, Bready J, Chen D, Choquette D, Coxon A, DeMelfi T, DiPietro L, Doerr N, Estrada J, Flynn J, Graceffa RF, et al. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. Journal of Medicinal Chemistry. 51: 1649-67. PMID 18324761 DOI: 10.1021/jm701097z  0.473
2008 Reisman SE, Ready JM, Weiss MM, Hasuoka A, Hirata M, Tamaki K, Ovaska TV, Smith CJ, Wood JL. Evolution of a synthetic strategy: total synthesis of (+/-)-welwitindolinone A isonitrile. Journal of the American Chemical Society. 130: 2087-100. PMID 18198870 DOI: 10.1021/Ja076663Z  0.716
2004 Ready JM, Reisman SE, Hirata M, Weiss MM, Tamaki K, Ovaska TV, Wood JL. A mild and efficient synthesis of oxindoles: progress towards the synthesis of welwitindolinone A isonitrile. Angewandte Chemie (International Ed. in English). 43: 1270-2. PMID 14991796 DOI: 10.1002/Anie.200353282  0.716
2003 Dounay AB, Hatanaka K, Kodanko JJ, Oestreich M, Overman LE, Pfeifer LA, Weiss MM. Catalytic asymmetric synthesis of quaternary carbons bearing two aryl substituents. Enantioselective synthesis of 3-alkyl-3-aryl oxindoles by catalytic asymmetric intramolecular heck reactions. Journal of the American Chemical Society. 125: 6261-71. PMID 12785859 DOI: 10.1021/Ja034525D  0.316
1999 Wood JL, Holubec AA, Stoltz BM, Weiss MM, Dixon JA, Doan BD, Shamji MF, Chen JM, Heffron TP. Application of reactive enols in synthesis: A versatile, efficient, and stereoselective construction of the welwitindolinone carbon skeleton [11] Journal of the American Chemical Society. 121: 6326-6327. DOI: 10.1021/Ja991022S  0.656
Show low-probability matches.